Biotechnology
Company Overview of X-Ceptor Therapeutics, Inc.
Key Executives for X-Ceptor Therapeutics, Inc.
| Name | Board Relationships | Title | Age |
| George A. Scangos Ph.D. | 124 Relationships | Chief Executive Officer and President | 64 |
X-Ceptor Therapeutics, Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| Arthur J. Klausner MBA | 17 Relationships | Edge Therapeutics, Inc. | 52 |
X-Ceptor Therapeutics, Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||
CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | 385.7K | |
| Bonus | 263.7K | |
| Total Short Term Compensation | 480.3K | |
| Total Value of Options | 13.3M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact X-Ceptor Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








